Facts & Risks

Educate Your Family on Dangers of Marijuana Use

Marijuana use comes with real risks that can impact a person’s health and life.

Whether marijuana is smoked, vaped, or eaten, there are adverse effects associated with use in any form.

Studies have found marijuana is an addictive, harmful, and mind altering drug. It over-activates parts of the brain and negatively affects brain development. Marijuana leads to physical health problems, mental health problems, and risk of addiction.

With the legalization of medical and recreational marijuana throughout the United States, marijuana potency has increased exponentially. Concentrates are not the traditional joint of the past. Concentrates are highly potent, THC-rich forms of marijuana that can be vaped, dabbed, and used in edibles.

Exposure to high levels of THC, the chemical in marijuana that causes impairment, increases the risks of physical dependence and addiction. Higher doses of THC are more likely to produce anxiety, agitation, paranoia, and psychosis.

Arizona Parents: Do you need tips on how to talk to your child about the new recreational marijuana laws? Download these talking tips today.

Surgeon General Advisory

“This ain’t your mother’s marijuana… the marijuana of today is significantly more potent.”

– VADM Jerome Adams, the first Surgeon General Advisory on marijuana since 1982

4

What do you know about marijuana

1 / 5

Using marijuana can lead to a _________ point drop in IQ.

2 / 5

How much THC can an edible have in it?

3 / 5

Cannabis use is linked to an increased risk of ______________?

4 / 5

______% of those who start using marijuana in their teens become addicted.

5 / 5

Kids are _____________ weed at alarming rates.

Your score is

The average score is 40%

0%

Exit

%

Almost 30% of teens have used marijuana - this is TOO many!

Latest Studies

Legalization of Smokable Medical Cannabis and Changes in the Dispensed Amount of Δ-9 Tetrahydrocannabinol Per Patient ​​​| PubMed | 10/7/2024

Abstract
Introduction: Florida’s medical cannabis (marijuana) program is among the largest in the United States. Smokable cannabis forms were not legally available in this program until 2019, and five years after other forms of cannabis were available. This study assessed changes in Δ-9 tetrahydrocannabinol (THC) dispensed per patient following legalization of smokable cannabis in Florida. Materials and Methods: This quasi-experimental study used data from the Florida Department of Health Office of Medical Marijuana Use Reports on THC dispensing from April 6, 2018, through March 13, 2020. Certified medical cannabis user during the study period was included. The exposure was the dispensed amount of THC from legalized smokable forms of medical cannabis (statute identified as SB182), effective as of March 2019. Changes in level and trend of average milligram (mg) of dispensed THC per certified patient with 95% confidence intervals (CIs), before and after SB182, were calculated by fitting a generalized least squares linear model and allowing a 17-week phase-in period. Results: The number of certified patients increased by 24.8% from 197,107 (March 22, 2019) to 246,079 (July 19, 2019) and to 325,868 by March 13, 2020. Assuming that a 20% THC concentration in smokable products, there was a significant level increase in the mean weekly dispensed THC amount per certified patient of 138.45 mg (95% CI: 102.69-174.20), translating to a 42.18% increase (95% CI: 33.14-50.28), from the pre-policy period. We noted a continuous increase of 5.62 mg per certified patient per week (95% CI: 4.35-6.89) throughout the 35 weeks following the policy, when compared with the period before. Assuming 10% THC concentration in smokable products, we observed a significant level increase of 35.10 mg (95% CI: 5.31-64.88), corresponding to an increase of 10.70% (95% CI: 1.70-18.89), and a trend increase of 2.23 mg per certified patient per week (95% CI: 1.18-3.29). Discussion: The expansion of the Florida medical cannabis program to include smokable cannabis forms was associated with a significant increase in the mean amount of weekly dispensed THC per certified patient. Findings suggest that the dispensed amount of THC after legalization of smokable medical cannabis far exceeds the maximum recommended daily dose, based on extrapolation from oral cannabis product dosing recommendations from one expert consensus statement, raising questions about the safety, and need for consumer education.

Read more

Cannabis Use During Adolescence and Young Adulthood and Academic Achievement
A Systematic Review and Meta-Analysis ​​​| JAMA | 10/7/2024

Key Points
Question What is the association between cannabis use during adolescence or young adulthood and academic achievement?

Findings In this meta-analysis of 63 studies including 438 329 individuals, moderate-certainty evidence showed cannabis use during adolescence and young adulthood is probably associated with lower school grades; less likelihood of high school completion, university enrollment, and postsecondary degree attainment; and increased school dropout rate and school absenteeism. Low-certainty evidence suggested cannabis use may be associated with increased unemployment.

Meaning Cannabis use during adolescence and young adulthood is associated with worse academic performance; further research is needed to mitigate upstream and downstream factors associated with early cannabis exposure.

Read more

Cannabis use patterns and association with hyperemesis: A comprehensive review​ ​​​| PubMed | 8/20/2024

Abstract
Background: Cannabis use in the general population is prevalent and is rising because of increased acceptance of its use, legalization in most US states, and perceived health benefits. Cannabis product potency has dramatically increased with higher delta-9-tetrahydrocannabinol content. Cannabis has documented antiemetic properties and cannabinoid pharmaceuticals are used in disorders like chemotherapy-induced nausea and vomiting.

Purpose: Forty to eighty percent of cyclic vomiting syndrome (CVS) patients use cannabis products, which reportedly reduce stress as well as nausea and vomiting. Cannabinoid hyperemesis syndrome (CHS) has a presentation similar to CVS, but is associated with longstanding, high dose cannabis use, and is thought to be relieved by sustained cannabis abstinence. Most CHS patients have used cannabis on a daily or near-daily basis for more than 2 years. Compulsive hot-water bathing behaviors are reported by most CHS patients, but are not specific for this disorder as they are also noted by about half of CVS patients. Episodic vomiting associated with cannabis use contributes to extensive health resource use, including emergency department visits and inpatient hospitalizations, and impacts patients and their families negatively. Treatment for CHS overlaps with CVS although cannabis abstinence remains the cornerstone of its management. Challenges associated with cannabis use cessation in CHS include patient skepticism of the role of cannabis as a cause of symptoms, perceived benefits of cannabis, and a lack of other effective therapies. In this review, we highlight cannabis use patterns in the US and discuss diagnosis and management of CHS and gaps in knowledge about this disorder

Read more

Prenatal Cannabis Use and Maternal Pregnancy Outcomes ​​​| JAMA | 7/22/2024

Key Points
Question Is prenatal cannabis use associated with maternal health outcomes during pregnancy?

Findings In this cohort study of 316 722 pregnancies, prenatal cannabis use was associated with increased risk of gestational hypertension, preeclampsia, weight gain greater and less than guidelines, and placental abruption as well as reduced risk of gestational diabetes. No association was found with eclampsia, placenta previa, placenta accreta, or severe maternal morbidity.

Meaning The results of this study suggest that the association between prenatal cannabis use and maternal health is complex and there is a need for continued research to understand how prenatal cannabis use affects the health of pregnant individuals.

Read more

Changes in self-reported cannabis use in the United States from 1979 to 2022 ​​​| Wiley | 6/22/2024

Abstract
Background and aims
Multiple countries are considering revising cannabis policies. This study aimed to measure long-term trends in cannabis use in the United States and compare them with alcohol use.

Design and setting
Secondary analysis of United States general population survey data.

Participants
The national surveys had a total of 1 641 041 participants across 27 surveys from 1979 to 2022.

Read more

Latest NEWS Commentary

THC in marijuana has ‘skyrocketed’ and it’s a ‘major problem’: Dr. Marc Siegel ​| FOX News | 5/24/2024

Fox News contributor Dr. Marc Siegel joins ‘America’s Newsroom’ to discuss the study finding more Americans use marijuana daily than alcohol.

Read more

High-potency marijuana highlights the risk of cannabis-induced psychiatric disorders ​| NBC | 4/24/2024

As more states legalize recreational cannabis products, there’s been greater consumer demand for more powerful weed, raising the possible of risk of psychiatric disorders.

Read more

Weed Is Dangerous. Legalizing It Was a Mistake ​| The Free Press | 3/12/2024

For years, cannabis advocates claimed that legalizing recreational marijuana would benefit America. But more than a decade into the experiment, it’s clear that legalization has been nothing short of a disaster.

Read more

Expert sounds alarm on danger of hemp products: ‘A matter of life and death’​​ ​| FOX News | 12/20/2023

Protect Our Kids CEO Luke Niforatos discusses growing concerns among parents and medical workers over children’s exposure to hemp-driven products.

Read more

Marijuana use during pregnancy linked to low birth weight, study finds​​ ​| NBC News | 12/12/2023

Researchers looked at data on more than 9,000 pregnant women and found that the risks associated with marijuana use went up the more marijuana a pregnant person consumed.

Read more

 

Stay Connected

Stay informed by connecting with us on social media and sign up to receive email newsletters.